All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe
Advertisement

Article

Equipment and Processing Report

February 18, 2009

Equipment and Processing Report

Equipment and Processing Report-02-18-2009
Volume0
Issue 0

February 2009 Editor's Picks: Products from Oystar USA and Schreiner MediPharm

Author(s):

Pharmaceutical Technology Editors

PharmTech's monthly newsletter, Equipment & Processing Report, reviews the Editor's Picks for the February 2009 edition from Oystar USA and Schreiner MediPharm.

Oystar USA
Press produces multilayer tablets

Oystar USA (Fairfield, NJ) offers its “FlexiTab” fully automated, single-station tablet press for small-batch production. The machine features a multilayer-tablet function to produce three-layer tablets.

The FlexiTab device is not fixed to a compression cycle, unlike other tablet presses. Parameters such as tablet weight, force, dwell, and thickness are adjustable through the unit’s touch-screen panel control system. The press’s hydraulic and pneumatic cylinders achieve compression forces as great as 100 kN and enable rapid punch displacement. Operators can thus simulate various rotary tablet presses at various speeds.

In addition to enabling the compression cycle to be modified, the FlexiTab unit’s computer and software can store compression-profile and tooling-list data. The machine uses standard Euro B and D tooling and can be operated in setup, series, step-by-step, and manual modes.

Schreiner MediPharm
Label system helps prevent injuries

The “Needle-Trap” system from Schreiner MediPharm (Blauvelt, NY) is a label for disposable syringes designed to protect healthcare providers from accidental needlestick injuries. The system comprises a self-adhesive syringe label with an integrated safety mechanism that secures the needle. Healthcare providers can easily uncover the needle to deliver an injection and secure it afterward, without altering their injection technique.

The Needle-Trap labels can be incorporated into common pharmaceutical labeling systems easily. The product is also available with optional detachable documentation labels intended to reduce the risk of medication errors. The labels can be adapted to the most common syringe types.

The system’s easy integration, flexibility, and process reliability make it a suitable solution for pharmaceutical manufacturers, according to the company. In addition, the Needle-Trap system meets healthcare professionals’ requirements for field-use safety.

Articles in this issue

Containment by Design for Cytotoxic Manufacturing
Bridging the Development–Manufacturing Gap to Achieve QbD and PAT
Oystar_flexitab_web-581280-1408661262799.jpg
February 2009 Editor's Picks: Products from Oystar USA and Schreiner MediPharm

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave A Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, CSO, AustinPx
Related Content
Advertisement
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 15th 2025

FDA Commissioner Applauds Florida Restriction on 7-OH Opioids

Susan Haigney
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 15th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Coronavirus 2019-nCov novel coronavirus concept resposible for asian flu outbreak and coronaviruses influenza as dangerous flu strain cases as a pandemic. The virus is made up of purple pills. | Image Credit: © lunarts_studio - stock.adobe.com
August 15th 2025

BARDA Pulls Plug on Vaxart Oral COVID Vaccine Trial After mRNA Rollback

Patrick Lavery
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 15th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Stem cells - undifferentiated (immature) cells on the background of a DNA helix, 3d rendering | Image Credit: © ustas - stock.adobe.com
August 15th 2025

Optimizing Testing in Cell and Gene Therapy: A Key Driver for Industry Growth and Adoption

Ambili Menon
Pendulum used for readings and hypnotism swinging with motion blur | Image Credit: © fergregory - stock.adobe.com
August 15th 2025

Prasad Returns to Head FDA’s CBER

Christopher Cole
Related Content
Advertisement
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 15th 2025

FDA Commissioner Applauds Florida Restriction on 7-OH Opioids

Susan Haigney
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 15th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Coronavirus 2019-nCov novel coronavirus concept resposible for asian flu outbreak and coronaviruses influenza as dangerous flu strain cases as a pandemic. The virus is made up of purple pills. | Image Credit: © lunarts_studio - stock.adobe.com
August 15th 2025

BARDA Pulls Plug on Vaxart Oral COVID Vaccine Trial After mRNA Rollback

Patrick Lavery
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 15th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Stem cells - undifferentiated (immature) cells on the background of a DNA helix, 3d rendering | Image Credit: © ustas - stock.adobe.com
August 15th 2025

Optimizing Testing in Cell and Gene Therapy: A Key Driver for Industry Growth and Adoption

Ambili Menon
Pendulum used for readings and hypnotism swinging with motion blur | Image Credit: © fergregory - stock.adobe.com
August 15th 2025

Prasad Returns to Head FDA’s CBER

Christopher Cole
About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.